Consonance Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Consonance Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-830,151	Closed	-$48M	–	33
2015 Q1	$48M	Sell	830,151 -639,539	-44%	-$27.2M	4.37%	10
2014 Q4	$47.4M	Buy	1,469,690 +431,137	+42%	+$12.9M	6.11%	7
2014 Q3	$25.4M	Buy	1,038,553 +150,347	+17%	+$3.05M	3.49%	12
2014 Q2	$15.7M	Sell	888,206 -722,261	-45%	-$11.6M	2.34%	19
2014 Q1	$32.2M	Buy	1,610,467 +240,587	+18%	+$4.66M	4.79%	9
2013 Q4	$23M	Buy	1,369,880 +632,195	+86%	+$8.75M	3.77%	16
2013 Q3	$7.83M	Buy	+737,685	New	+$6.45M	1.96%	18

Other funds holding ANAC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

RCP

Rho Capital Partners New York $20.4M AUM

Consonance Capital Management's ANAC Position: Q2 2015 in Review

Consonance Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2015, closing a stake of 830,151 shares — an estimated $48M sold.

Consonance Capital Management first reported a position in ANAC in Q3 2013 and held it in 7 quarters. The position peaked at $48M in Q1 2015. 177 funds tracked by Wall St. Rank hold ANAC as of Q2 2015.

Consonance Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2015 after selling out during the quarter.
Consonance Capital Management sold 830,151 ANACOR PHARMACEUTICALS INC COM shares in Q2 2015, an estimated $48M.
Consonance Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 7 quarters.
Consonance Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $48M in Q1 2015.
177 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2015.

Based on Consonance Capital Management's 13F filing for Q2 2015, filed 12 Aug 2015.